September 26, 2025 · Form 4 insider transaction
Stockwell Lynn sold 7,966,667 shares of DMII, a transaction worth N/A. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
As of the Transaction Date, pursuant to share transfer agreements, the sponsor transferred an aggregate of 7,966,667 ordinary shares to a number of accredited investors for consideration ranging from no consideration to $1.50 per share.; Reflects 700,000 private units acquired by Drugs Made In America Acquisition II LLC, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-tenth (1/10) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $7,000,000. Lynn Stockwell is the managing member of the sponsor and has voting and dispositive power over the securities held of record by the sponsor. Ms. Stockwell disclaims any beneficial ownership of the securities held by the sponsor, except to the extent of her pecuniary interest therein.